October 29, 2020
Alexandria Center for Life Science*
New York City – 7:00 am – 4:00 pm

…with top scientists, executive and thought leaders from academic and private research who offer perspectives on the most significant challenges in the global burden of disease and highlight the latest research and clinical pathways toward diagnosis, treatment, and cure.

Register

Co-Chairs


Pr Sue DESMOND-HELLMANN, M.D., M.Ph.
Prix Galien USA Committee Chair;
Former Chief Executive Officer of the Bill & Melinda Gates Foundation

Dr Michael ROSENBLATT M.D.
Prix Galien USA Committee Member;
Chief Medical Officer of Flagship Pioneering


*The Galien Forum and Prix Galien USA Ceremony will take place on October 29, 2020, though in order to ensure the safety of all participants our format may shift in keeping with COVID-19-related guidelines issued by the Centers for Disease Control and Prevention (CDC) and New York City authorities. The Galien Foundation is considering and planning for multiple scenarios, including a smaller in-person event with digital access, a partially virtual event, and a completely virtual event. Updates will be posted and shared with our network via email as soon as they are confirmed. 

Speakers


Mikael DOLSTEN
Chief Scientific Officer & President, Worldwide Research, Development and Medical (WRDM), Pfizer Inc.

Anthony S. FAUCI
Director, NIAID*

Ken FRAZIER
Chief Executive Officer, Merck & Co.

Joe GOLDSTEIN
Nobel Laureate & Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center. Prix Galien USA Committee Member

Penny HEATON
Chief Executive Officer, Bill & Melinda Gates Medical Research Institute

Carl JUNE
Director of the Center for Cellular Immunotherapies, UPenn

Dean LI
Senior VP, Discovery & Translational Sciences, Merck & Co.

John MARAGANORE
Chief Executive Officer, Alnylam

Joel S. MARCUS
Co-chair, Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit

Elizabeth NABEL
Chief Executive Officer, Brigham and Women’s Hospital

Mene PANGALOS*
Executive Vice-President, BioPharmaceuticals R&D, AstraZeneca

Michael RINGEL
Managing Director & Senior Partner, BCG

Mike ROSENBLATT
CMO, Flagship Pioneering &  Chief Medical Officer, Flagship Pioneering. Co-Chair Galien Forum. Prix Galien USA Committee Member

Steve ROSENBERG
Senior Vice President and General Manager, Oracle Health Sciences

George SCANGOS
Chief Executive Officer, Vir Biotechnology

Nancy SIMONIAN
President & Chief Executive Officer, Syros

P. Roy VAGELOS
Chairman of Regeneron Pharmaceuticals and Retired Chairman and Chief Executive Officer of Merck & Co., Inc. Prix Galien USA Committee Member

Michel VOUNATSOS
Chief Executive Officer, Biogen

George YANCOPOULOS
President & Chief Scientific Officer, Regeneron

Lynne ZYDOWSKY
Co-chair, PhD, Chief Science Officer, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; President & Co-Founder Alexandria Summit

* (TBC)
Non definitive list

Download the Galien Forum App >